Name: | dipivefrin |
---|---|
PubChem Compound ID: | 1150214 |
Molecular formula: | C19H29NO5 |
Molecular weight: | 351.437 g/mol |
Synonyms: |
NCGC00016906-01; CAS-64019-93-8
|
Name: | dipivefrin |
---|---|
Name (isomeric): | DB00449 |
Drug Type: | small molecule |
Brand: | Dipivefrina [INN-Spanish], Dipivefrin HCL, Dipivefrine, AKPro, DPE, Propine C Cap B.I.D., Ophtho-Dipivefrin, Dipivefrinum [INN-Latin], Dipivefrin [USAN], Propine |
Brand name mixture: | Probeta - Liq Oph(Dipivefrin Hydrochloride + Levobunolol Hydrochloride) |
Category: | Ophthalmologicals, Sympathomimetics, Adrenergic Agonists |
CAS number: | 52365-63-6 |
Indication: | Dipivefrin is a prodrug which is used as initial therapy for the control of intraocular pressure in chronic open-angle glaucoma. |
---|---|
Pharmacology: |
Dipivefrin is a member of a class of drugs known as prodrugs. Prodrugs are usually not active in themselves and require biotransformation to the parent compound before therapeutic activity is seen. These modifications are undertaken to enhance absorption, decrease side effects and enhance stability and comfort, thus making the parent compound a mor...
show more » |
Mechanism of Action: |
Dipivefrin is a prodrug with little or no pharmacologically activity until it is hydrolyzed into epinephrine inside the human eye. The liberated epinephrine, an adrenergic agonist, appears to exert its action by stimulating α -and/or β2-adrenergic receptors, leading to a decrease in aqueous production and an enhancement of outflow facili...
show more » |
Absorption: | Well absorbed following occular administration. |
Biotransformation: | Dipivefrin is converted to epinephrine inside the human eye by enzyme hydrolysis. |
Toxicity: | Oral LD50 in rat is 183 mg/kg. |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|